CAMELOT FANTASIES

Aurora Cannabis Inc.'s all-stock hostile takeover bid of medical marijuana company CanniMed Therapeutics has the backing of a Toronto-based investment manager, two Saskatchewan venture capital funds, and an investment fund also based in the prairie province, according to regulatory filings.
Shares of Aurora (TSX:ACB) were up as much as 16 per cent in late afternoon trading after the Vancouver-headquartered marijuana producer officially launched its bid on Friday, while shares of CanniMed (TSX:CMED) slipped as much as 3 per cent by early afternoon in Toronto.
Aurora signed lock-up agreements with four CanniMed shareholders — which comprise 38 per cent of outstanding shares — on Nov. 13 to support its unsolicited takeover bid, one day before it made its proposal public, according to a circular outlining its offer.

These four institutional shareholders are Golden Opportunities Fund Inc. with a 17.33 per cent stake, Saskworks Venture Fund Inc. with 8.42 per cent, Apex Investment Limited Partnership with 3.48 per cent and Toronto's Vantage Asset Management holding 8.71 per cent, filings show.